CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China Yahoo Finance Nawigacja wpisu 1st batch of Molnupiravir available at mainland hospitals as new option for COVID-19 patients – Global Times CARsgen Therapeutics and Huadong Medicine Announce … – PR Newswire